• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges

    Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention

    New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance

    Tapping Functional Beverages to Meet Modern Wellness Needs

    Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Florida Food Products Acquires Javo

    Roquette Launches Nutralys Rice Protein

    New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy

    CTRL Launches Meal On-The-Go Bars

    GNC and RealEats Meal Delivery Partnership Expands Nationally
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Roquette Launches Nutralys Rice Protein

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development

    Study Reveals Low Intake of Tocotrienols in Polish Population

    Combination of Collagen and Boswellia Serrata Shown to Reduce Joint Discomfort

    Nutralliance Adds Eggshell-Derived Ingredients for Beauty and Joint Health to Portfolio
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Florida Food Products Acquires Javo

    Roquette Launches Nutralys Rice Protein

    New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy

    CTRL Launches Meal On-The-Go Bars

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development

    Botanical Gum for Kids Aims to Curb Sugar Cravings

    Combination of Collagen and Boswellia Serrata Shown to Reduce Joint Discomfort

    Childhood Fitness and Obesity Impact Cognition Later in Life, Study Finds

    Nutralliance Adds Eggshell-Derived Ingredients for Beauty and Joint Health to Portfolio
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Sabinsa Corporation

    Verdure Sciences

    JRS Pharma

    Bioactive Resources

    Xsto Solutions
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Sabinsa Corporation

    Verdure Sciences

    JRS Pharma

    Bioactive Resources

    Xsto Solutions
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Habitual Fish Oil Use Significantly Reduced CVD and All-Cause Mortality Rates

    In the largest-scale study of its kind to date, researchers tracked the health outcomes of nearly half a million middle-aged participants in the U.K.

    Habitual Fish Oil Use Significantly Reduced CVD and All-Cause Mortality Rates
    While the best formulations and doses could not be determined with the information provided, the study boasted strength in numbers.
    Related CONTENT
    • Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study
    • STRENGTH Trial Finds Omega-3s Didn’t Reduce Cardiovascular Event Risk
    • Omega-3s Associated with Better Liver Functioning In NAFLD Patients
    By Mike Montemarano, Associate Editor, Nutraceuticals World03.10.20
    A study published on March 4 in the BMJ Medical Journal yielded evidence that habitual fish oil supplementation significantly reduces the risk of all-cause mortality, cardiovascular disease (CVD) mortality, and mortality from CVD incident events.
     
    Fish oil, a rich source of the long-chain omega-3 fatty acids EPA and DHA, has been attached to several large-scale randomized controlled trials, in an attempt to prove that it significantly reduces the risk of CVD and related health incidents. Some studies have previously found statistically significant evidence suggesting the positive health claim, while others have yielded correlations too small to be considered significant.
     
    Of the UK Biobank participants who were evaluated, 31.2% of the participants reported habitual use of fish oil supplements. Using multivariable adjusted hazard ratios for the habitual users versus non-users of fish oil, the researchers found that those who took fish oil saw a 13% reduction in all-cause mortality rates, a 16% reduction in cardiovascular disease mortality rates, and a 7% reduction in incident CVD events compared to the majority of the group which didn’t use the supplement.
     
    “Habitual use of fish oil seems to be associated with a lower risk of all cause and CBD mortality and to provide a marginal benefit against CVD events among the general population,” the researchers concluded. “The protective association of fish oil use against CVD events was somewhat stronger in those with prevalent hypertension.”
     
    Further research is required to determine what function fish oil serves in relation to clinical outcomes. “Several mechanisms could explain the benefits for clinical outcome derived from fish oil supplementation,” researchers said. “Firstly, the results of several studies have indicated that supplementation with omega 3 fatty acids has beneficial effects on blood pressure, plasma triglycerides, and heart rate, all of which would exert a protective effects against the development of CVD. Secondly, several trials have shown that omega 3 fatty acids can improve flow mediated arterial dilation, which is a measure of endothelial function and health. Thirdly, omega 3 fatty acids have been shown to possess antiarrhythmic properties that could be clinically beneficial. Finally, studies have reported that fish oil can reduce thrombosis.”
     
    The BMJ cohort study, likely the largest-scale study of its kind to date, tracked the health outcomes of 427,678 men and women aged between 40 and 69 who had no CVD or cancer at baseline, who enrolled in the study between 2006 and 2010 and were followed up with at the end of 2018.
     
    While the study possessed strengths which included a population-based cohort of nearly a half-million participants to show fish oil’s effectiveness in a real-life setting, including detailed information on individual factors, some limits included the detailed information on supplementation itself. Researchers did not elicit detailed information on supplement use itself, such as the dose, formulation, and duration of use.
     
    “The lack of such information precluded us from evaluating dose-response associations between fish oil supplementation and outcomes, the independent effects and best ratio of the individual components of fish oil supplements, and the optimal duration of fish oil supplementation,” the study authors wrote. It is also difficult to comment on the dose of fish oil supplements needed to achieve a clinically meaningful effect.”
     
    Participants completed a questionnaire, a face-to-face interview, and provided biological samples and physical measurements to researchers. Participants with incomplete data on the use of fish oil (declined to say “yes” or “no” when asked if they habitually use fish oil), those with CVD or cancer at baseline, or those who subsequently withdrew from the study were excluded from the analysis by researchers. At the end of the study, participants’ health outcomes had been monitored for a median of nine years.
     
    Researchers also used the questionnaire to identify several possible counfounding variables to minimize inferential bias and adjust accordingly, including demographic factors, socioeconomic status, lifestyle habits, body mass index, physical activity, dietary intake, drug use, and other dietary supplementations.
     
     
     
    Related Searches
    • Omega 3
    • EPA
    • Cancer
    • Health
    Related Knowledge Center
    • Omega-3s
    • Research
    • Cardiovascular Health
    Suggested For You
    Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study
    STRENGTH Trial Finds Omega-3s Didn’t Reduce Cardiovascular Event Risk STRENGTH Trial Finds Omega-3s Didn’t Reduce Cardiovascular Event Risk
    Omega-3s Associated with Better Liver Functioning In NAFLD Patients Omega-3s Associated with Better Liver Functioning In NAFLD Patients

    Related Breaking News

    • Bone & Joint Health | Breaking News | Dietary Supplements | Functional Foods & Beverages | Inflammation | Natural/Organic | Omega-3s | Research | Research News | Sports Nutrition
      Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study

      Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study

      Improvements in range of motion and serum creatine kinase levels following exercise suggests that EPA-rich fish oil has a unique sports nutrition benefit.
      Mike Montemarano, Associate Editor 04.13.21

    • Breaking News | Cardiovascular Health | Dietary Supplements | Medical Nutrition | Omega-3s | Research | Research News | World Markets
      STRENGTH Trial Finds Omega-3s Didn’t Reduce Cardiovascular Event Risk

      STRENGTH Trial Finds Omega-3s Didn’t Reduce Cardiovascular Event Risk

      No significant differences were observed between omega-3s and corn oil in major adverse cardiovascular outcomes in a study published in JAMA.
      11.16.20

    • Breaking News | Dietary Supplements | Medical Nutrition | Natural/Organic | Omega-3s | Research | Research News
      Omega-3s Associated with Better Liver Functioning In NAFLD Patients

      Omega-3s Associated with Better Liver Functioning In NAFLD Patients

      Non-alcoholic fatty liver disease affects up to 25% of the population worldwide.
      11.03.20


    Trending
    • Three Grams Of Omega-3s May Be Optimal Dose For Reducing Blood Pressure
    • 3 grams of Omega-3s May be Optimal Dose for Reducing Blood Pressu
    • Olive/Pomegranate Extract May Improve Dyslipidemia
    Breaking News
    • Florida Food Products Acquires Javo
    • Roquette Launches Nutralys Rice Protein
    • New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy
    • CTRL Launches Meal On-The-Go Bars
    • GNC and RealEats Meal Delivery Partnership Expands Nationally
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • Tapping Functional Beverages to Meet Modern Wellness Needs
    • Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    • New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    • Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges
    • Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Florida Food Products Acquires Javo
    Roquette Launches Nutralys Rice Protein
    New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy
    Coatings World

    Latest Breaking News From Coatings World

    The Southern Society for Coatings Technology's 84th Annual Technical Conference A Success
    PPG to Showcase Specialty Automotive, Aerospace Adhesives, Sealants at Adhesives & Bonding Expo
    PPG’s New Paint for a New Start Initiative to Transform 25-plus Schools Worldwide
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most Read Stories This Week—June 25
    Magnetic Insight Announces $17 Million in Series B Funding
    BreatheSuite Adds Brad Fluegel to its Board
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pierre Fabre and Lonza Enter Manufacturing Agreement
    MasterControl and Elemental Machines Form Biomanufacturing Partnership
    Qosina Strengthens Aseptic Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Benefit Exec Joins Madison Reed's Board
    Peroni & Ellis Brooklyn Launch Fragrance Collection Inspired by Italian Spritz Cocktails
    Rhode Is Trending for June, Trendalytics Says
    Happi

    Latest Breaking News From Happi

    A Suitor Emerges for Revlon, SK Capital’s New Dealmaker & P&G’s Indoor Air Quality Efforts
    Wonder Curl Wins GlossWire's GlossPitch Competition
    Anti-aging Skincare Brand Vitabrid C12 Launches Bestsellers on Amazon
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: INX’s VC Fund, Screen Industry and Ball Top This Week’s News
    British Coatings Federation Posts Online History
    Orion Announces Price Increases, Reduced Payment Terms
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PCMC teams with IGT, Fujifilm makes big announcement and more
    Loftware recognized as 'AIDC Company of the Year'
    Schreiner MediPharm highlights sustainability of Needle-Trap technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Tranzonic Names VP of Supply Chain
    Ontex Climate Action Targets Approved by Science-Based Targets Initiative
    Suominen Test Center Assesses Biodegradability of Nonwovens
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—June 25
    3Spine Inc. Receives IDE Approval for U.S. Pivotal Clinical Trial
    Volume-Based Procurement to Reduce Chinese Orthopedic Market Value
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: eMagin, Applied Materials, and Schott Top This Week’s Stories
    NREL Names Jennifer Logan to Leadership Team as CFO
    National Grid Renewables Orders 2 GW of First Solar Modules

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login